Production of Granulocyte Colony-Stimulating Factor in the Nonspecific Acute Phase Response Enhances Host Resistance to Bacterial Infection
Open Access
- 15 July 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 169 (2) , 913-919
Abstract
Mice mounting an acute phase response, induced by sterile inflammation after a single s.c. injection of casein 24 h beforehand, were remarkably protected against lethal infection with Gram-positive or Gram-negative bacteria. This was associated with enhanced early clearance of bacteremia, greater phagocytosis and oxidative burst responses by neutrophils, and enhanced recruitment of neutrophils into tissues compared with control, nonacute phase mice. Casein-induced inflammation was also associated with increased concentrations of G-CSF in serum, and administration of neutralizing Ab to this cytokine completely abrogated protection against Escherichia coli infection after casein pretreatment. Injection of recombinant murine G-CSF between 3 and 24 h before infection conferred the same protection as casein injection. In contrast, the casein-induced acute phase response affected neither serum values of TNF-α, IL-1β, or IL-6 after E. coli infection nor susceptibility to LPS toxicity. Furthermore, protection against infection was unaffected in IL-1R knockout mice, which have deficient acute phase plasma protein responses, or after nonspecific inhibition of acute phase protein synthesis by d-galactosamine or specific depletion of complement C3 by cobra venom factor. Increased production of G-CSF in the acute phase response is thus a key physiological component of host defense, and pretreatment with G-CSF to prevent bacterial infection in at-risk patients now merits further study, especially in view of increasing bacterial resistance to antibiotics.Keywords
This publication has 21 references indexed in Scilit:
- Involvement of the Acute Phase Protein α1-Acid Glycoprotein in Nonspecific Resistance to a Lethal Gram-negative InfectionJournal of Biological Chemistry, 2000
- A Randomized Controlled Trial of Filgrastim as an Adjunct to Antibiotics for Treatment of Hospitalized Patients with Community‐Acquired PneumoniaThe Journal of Infectious Diseases, 1998
- Streptococcal Pyrogenic Exotoxin A Release, Distribution, and Role in a Murine Model of Fasciitis and Multiorgan Failure Due to Streptococcus pyogenesThe Journal of Infectious Diseases, 1996
- American Society of Clinical Oncology guidelines for the clinical use of hematopoietic colony-stimulating factorsCurrent Opinion in Hematology, 1996
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- TREATMENT OF INTRA-ABDOMINAL INFECTION WITH GRANULOCYTE COLONY-STIMULATING FACTOR1992
- Endotoxin tolerance: In vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional levelCellular Immunology, 1992
- Granulocyte Colony-Stimulating Factor Enhances Pulmonary Host Defenses in Normal and Ethanol-Treated RatsThe Journal of Infectious Diseases, 1991
- Simultaneous flow cytometric method to measure phagocytosis and oxidative products by neutrophilsCytometry, 1991
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982